Fig. 3From: Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational studyProbability of target attainment in cerebrospinal fluid (CSF) for different dosing regimens as prolonged infusions over 4 h. The proportions of simulated patients who exceeded meropenem trough concentrations in CSF greater than or equal to 1 mg/L, 2 mg/L and 4 mg/L for each regimen are shownBack to article page